Representative Transactions - Private Equity/Venture Capital - Taiwan

Represent premier U.S. biotechnology venture capital company in its investment in a Taiwanese biopharmaceutical company, which included implementing Silicon Valley-style venture capital terms under the Taiwan Company Law structure.
Represent global private equity firm in its acquisition of a Keelung-based Japanese inverter manufacturer
Advise Canadian corporation in the acquisition of language-teaching software company
Advise Australian financial services corporation with the sale of its Taiwan operations.
Represent NASDAQ-listed company in its acquisition of two Taiwan-based ISPs.
Represent Taiwan public software company in investment negotiations with a NASDAQ-listed semiconductor company.
Represent Taiwan-based satellite direct broadcast company in its formation and initial private placement of equity with angel investors from different parts of the world.
Represent multinational, U.S. public telecommunications company in negotiations for a global network management agreement with a Taiwan public computer company.
Represent Taiwan-based interactive internet music company in negotiating and forming a cross-border joint venture.
Represent U.S. based biotechnology start-up company in a U.S. $10 million Regulation S private placement of preferred stock with institutional investors in Taiwan.
Represent Taiwan public pharmaceutical company in negotiating and forming a U.S. $10 million biotechnology joint venture.
Represent NASDAQ-listed internet portal company in its joint venture with a TAIEX-listed computer company to create an Asian content portal.
Represent Taiwan-based music recording company in its formation and its U.S. $22.5 million private offering of equity to institutional investors.
Represent and create Taiwan's largest offshore and onshore B2B company, including portal, vertical industry and supply chain management components, among many of the largest public high tech and industrial groups in Taiwan.